241 related articles for article (PubMed ID: 32057906)
1. Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to rats.
Inoue D; Furubayashi T; Tanaka A; Sakane T; Sugano K
Eur J Pharm Biopharm; 2020 Apr; 149():145-153. PubMed ID: 32057906
[TBL] [Abstract][Full Text] [Related]
2. [Development of Prediction System for Drug Absorption after Intranasal Administration Incorporating Physiologic Functions of Nose -Estimation of in Vivo Drug Permeation through Nasal Mucosa Using in Vitro Membrane Permeability].
Inoue D
Yakugaku Zasshi; 2021; 141(11):1235-1240. PubMed ID: 34719543
[TBL] [Abstract][Full Text] [Related]
3. Kinetic model to predict the absorption of nasally applied drugs from in vitro transcellular permeability of drugs.
Furubayashi T; Kamaguchi A; Kawaharada K; Masaoka Y; Kataoka M; Yamashita S; Higashi Y; Sakane T
Biol Pharm Bull; 2007 May; 30(5):1007-10. PubMed ID: 17473453
[TBL] [Abstract][Full Text] [Related]
4. Permeation of losartan across human respiratory epithelium: an in vitro study with Calu-3 cells.
Amoako-Tuffour M; Yeung PK; Agu RU
Acta Pharm; 2009 Dec; 59(4):395-405. PubMed ID: 19919929
[TBL] [Abstract][Full Text] [Related]
5. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.
Gonçalves VSS; Matias AA; Poejo J; Serra AT; Duarte CMM
Int J Pharm; 2016 Dec; 515(1-2):1-10. PubMed ID: 27702697
[TBL] [Abstract][Full Text] [Related]
6. In situ gels of Metoclopramide Hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits.
Mahajan HS; Gattani S
Drug Deliv; 2010 Jan; 17(1):19-27. PubMed ID: 19958151
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Estimation of the Effect of Nasal Mucociliary Function on in Vivo Absorption of Norfloxacin after Intranasal Administration to Rats.
Inoue D; Kimura S; Kiriyama A; Katsumi H; Yamamoto A; Ogawara KI; Higaki K; Tanaka A; Yutani R; Sakane T; Furubayashi T
Mol Pharm; 2018 Oct; 15(10):4462-4469. PubMed ID: 30165013
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats.
Furubayashi T; Kamaguchi A; Kawaharada K; Masaoka Y; Kataoka M; Yamashita S; Higashi Y; Sakane T
Biol Pharm Bull; 2007 Mar; 30(3):608-11. PubMed ID: 17329868
[TBL] [Abstract][Full Text] [Related]
9. Permeability characteristics of calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats.
Mathia NR; Timoszyk J; Stetsko PI; Megill JR; Smith RL; Wall DA
J Drug Target; 2002 Feb; 10(1):31-40. PubMed ID: 11996084
[TBL] [Abstract][Full Text] [Related]
10. Modulating nasal mucosal permeation using metabolic saturation and enzyme inhibition techniques.
Dhamankar V; Donovan MD
J Pharm Pharmacol; 2017 Sep; 69(9):1075-1083. PubMed ID: 28542812
[TBL] [Abstract][Full Text] [Related]
11. Development and application of an ex vivo fosphenytoin nasal bioconversion/permeability evaluation method.
Antunes Viegas D; Rodrigues M; Francisco J; Falcão A; Alves G; Santos AO
Eur J Pharm Sci; 2016 Jun; 89():61-72. PubMed ID: 27106504
[TBL] [Abstract][Full Text] [Related]
12. Permeation and systemic absorption of R- and S-baclofen across the nasal mucosa.
Zhang H; Schmidt M; Murry DJ; Donovan MD
J Pharm Sci; 2011 Jul; 100(7):2717-23. PubMed ID: 21283988
[TBL] [Abstract][Full Text] [Related]
13. Improved nasal bioavailability of elcatonin by insoluble powder formulation.
Ishikawa F; Katsura M; Tamai I; Tsuji A
Int J Pharm; 2001 Aug; 224(1-2):105-14. PubMed ID: 11472819
[TBL] [Abstract][Full Text] [Related]
14. Suitability and functional characterization of two Calu-3 cell models for prediction of drug permeability across the airway epithelial barrier.
Sibinovska N; Žakelj S; Roškar R; Kristan K
Int J Pharm; 2020 Jul; 585():119484. PubMed ID: 32485216
[TBL] [Abstract][Full Text] [Related]
15. Permeability of porcine nasal mucosa correlated with human nasal absorption.
Wadell C; Björk E; Camber O
Eur J Pharm Sci; 2003 Jan; 18(1):47-53. PubMed ID: 12554072
[TBL] [Abstract][Full Text] [Related]
16. Development and
Wang D; Du Y; Zhang W; Han X; Zhang H; Wang Z; Liu N; Li M; Gao X; Zhuang X; Gao J; Zheng A
Drug Deliv; 2021 Dec; 28(1):487-498. PubMed ID: 33657948
[TBL] [Abstract][Full Text] [Related]
17. Zolpidem Mucoadhesive Formulations for Intranasal Delivery: Characterization, In Vitro Permeability, Pharmacokinetics, and Nasal Ciliotoxicity in Rats.
Wang Y; Li M; Qian S; Zhang Q; Zhou L; Zuo Z; Lee B; Toh M; Ho T
J Pharm Sci; 2016 Sep; 105(9):2840-2847. PubMed ID: 27189774
[TBL] [Abstract][Full Text] [Related]
18. The nasal delivery of systemic drugs.
Jones NS; Quraishi S; Mason JD
Int J Clin Pract; 1997; 51(5):308-11. PubMed ID: 9489091
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
[TBL] [Abstract][Full Text] [Related]
20. Permeability issues in nasal drug delivery.
Arora P; Sharma S; Garg S
Drug Discov Today; 2002 Sep; 7(18):967-75. PubMed ID: 12546871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
